ytb323
novartis
['dlbcl', 'ytb323', 'improve ', 'novartis', '$nvs']
 for a buyout i think novartis $nvs should do it. their science would complement each other very well. t-charge fast production of naive cells would further improve auto1/22 (eha abstract mentioned specifically more memory cells.) +ytb323 in dlbcl was weaker than auto1. $autl
The mediator